|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 601 13th St., NW |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20005-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46676-12
|
||||||||
|
6. House ID# 395790000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: AMY E. MODLIN |
Date | 7/19/2024 9:59:28 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues
Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Maternal Health; CMS Transforming Maternal Health (TMaH) model; Preventive Services; Data Equity; Hospital Billing
Bills
S.2556 - Improving CARE for Youth Act
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Sen. Carper, Thomas R. [D-DE]
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN]
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.4531 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
Sponsor: Rep. Guthrie, Brett [R-KY-2]
S.652 - Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.
Sponsor: Sen. Murkowski, Lisa [R-AK]
S. 1001 Telehealth Expansion Act of 2023
To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Sponsor: Sen. Daines, Steve [R-MT]
H.R.3630 - No Surprises Act
To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes.
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
S. 3393 - SUPPORT for Patients and Communities Reauthorization Act
To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes.
Sponsor: Sen. Sanders, Bernard [I-VT]
S.2016 - CONNECT for Health Act of 2023
To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes.
Sponsor: Sen. Schatz, Brian [D-HI]
S. 1451 Healthy Competition for Better Care Act
To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
Sponsor: Sen. Braun, Mike [R-IN]
S.1606 - Black Maternal Health Momnibus Act
To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
Sponsor: Sen. Booker, Cory A. [D-NJ]
S.2415 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Sen. Capito, Shelley Moore [R-WV]
S. 3548 Health Care PRICE Transparency Act
To amend the Public Health Service Act to provide for hospital and insurer price transparency.
Sponsor: Sen. Braun, Mike [R-IN]
H.R. 4581, Maternal and Child Health Stillbirth Prevention Act
To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes.
Sponsor: Rep. Hinson, Ashley [R-IA-2]
S. 3430, Better Mental Health Care, Lower Cost Drugs, and Extenders Act
To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes.
Sponsor: Sen. Wyden, Ron [D-OR]
H.R. 5066, Tech to Save Moms Act
To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes.
Sponsor: Rep. Williams, Nikema [D-GA-5]
H.R. 4818, Treat and Reduce Obesity Act
To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes.
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues
Same-day billing restrictions in Medicaid; Medicare Advantage (MA) & MA Rate Notice; 340B Program/Transparency
Bills
H.R.5746 - Addressing Whole Health in Medicare Advantage Act
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R.5380 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
Sponsor: Rep. Sarbanes, John P. [D-MD-3]
H.R.5388 - Supporting Innovation for Seniors Act
To amend title XVIII of the Social Security Act to provide coverage of certain technologies and medical devices under the Medicare program.
Sponsor: Rep. Balderson, Troy [R-OH-12]
H.R. 4605, Healthy Moms and Babies Act
To amend titles XIX and XXI of the Social Security Act to improve maternal health coverage under Medicaid and CHIP, and for other purposes.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R. 6860, Restore Protections for Dialysis Patients Act
To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act.
Sponsor: Rep. Kelly, Mike [R-PA-16]
H.R. 7623, Telehealth Modernization Act
To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R. 7996, Improving CARE for Youth Act
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
H.R. 8561, to amend title XVIII of the Social Security Act to address significant under projection of MA local area growth due to wage index reclassification
Sponsor: Rep. Tenney, Claudia [R-NY-24]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues
Generics access; Cell & Gene therapy; Step Therapy
Bills
S. 1114, Expanding Access to Low-Cost Generics Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
Sponsor: Sen. Smith, Tina [D-MN] "
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage.
Sponsor: Sen. Sanders, Bernard [I-VT]
S. 150 - Affordable Prescriptions for Patients Act of 2023
To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023
To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsor: Sen. Cantwell, Maria [D-WA]
S. 142 - Preserve Access to Affordable Generics and Biosimilars Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Sponsor: Sen. Amy Klobuchar (D-MN)
S.1542, DRUG Act
To improve services provided by pharmacy benefit managers.
Sponsor: Sen. Marshall, Roger [R-KS]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |